Skip to content
lifestyle.ketodash.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
CVRx, Inc.
CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026
October 22, 2026
CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026
September 29, 2026
CVRx Appoints John Landry as Chief Financial Officer
September 22, 2026
CVRx Responds to Letter from Pointillist Family Office
August 25, 2026
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
August 24, 2026
CVRx Announces Sales Leadership Transition
August 11, 2026
CVRx Reports Second Quarter 2026 Financial and Operating Results
August 6, 2026
CVRx to Present at Canaccord Genuity’s 46th Annual Growth Conference
July 28, 2026
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
May 22, 2026
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
May 20, 2026